Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrophysiological Effects of ABT-639 in Painful Diabetic Peripheral Neuropathy
NCT01589432Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ABT-639 in diabetic peripheral neuropathy (DPN), sponsored by AbbVie Inc.. Started Apr 2012; status: completed.
02
Drugs
ABT-639
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01589432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01589432.